J Int Assoc Physicians AIDS Care. 1998 Aug;4(8):19-25.

FDA approves rifapentine for the treatment of pulmonary tuberculosis.... Food and Drug Administration.

Abstract

AIDS:

Rifapentine was approved in June 1998 as a treatment for pulmonary tuberculosis. It is the first new drug approved for tuberculosis in 25 years. It will be sold under the name Priftin and will be available in October 1998. The protocol for the trial is described. Rifapentine will be used in combination with existing therapies, and its safety and efficacy are similar to Rifampin. The Food and Drug Administration praised the manufacturer, Hoechst Marion Roussel, for conducting trials overseas and seeking accelerated approval. There is very little data related to the use of the rifapentine in HIV- positive patients.

PMID:: 11365728; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

Newspaper Article

MeSH Terms

Substances

LinkOut - more resources

Medical

Molecular Biology Databases

RIFAMPIN - HSDB

Supplemental Content

Related citations

Acquired rifamycin monoresistance in patients with HIV-related tuberculosis treated with once-weekly rifapentine and isoniazid. Tuberculosis Trials Consortium. [Lancet. 1999]
Acquired rifamycin monoresistance in patients with HIV-related tuberculosis treated with once-weekly rifapentine and isoniazid. Tuberculosis Trials Consortium.
Vernon A, Burman W, Benator D, Khan A, Bozeman L. Lancet. 1999 May 29; 353(9167):1843-7.
Review Rifapentine for the treatment of pulmonary tuberculosis. [Clin Infect Dis. 2006]
Review Rifapentine for the treatment of pulmonary tuberculosis.
Munsiff SS, Kambili C, Ahuja SD. Clin Infect Dis. 2006 Dec 1; 43(11):1468-75. Epub 2006 Oct 24.
Researchers find new drugs to fight MAC. [AIDS Alert. 1995]
Researchers find new drugs to fight MAC.
. AIDS Alert. 1995 Nov; 10(11):138-9.
Weekly rifapentine/isoniazid or daily rifampin/pyrazinamide for latent tuberculosis in household contacts. [Am J Respir Crit Care Med. 2006]
Weekly rifapentine/isoniazid or daily rifampin/pyrazinamide for latent tuberculosis in household contacts.
Schechter M, Zajdenverg R, Falco G, Barnes GL, Faulhaber JC, Coberly JS, Moore RD, Chaisson RE. Am J Respir Crit Care Med. 2006 Apr 15; 173(8):922-6. Epub 2006 Feb 10.
Review A review of efficacy studies of 6-month short-course therapy for tuberculosis among patients infected with human immunodeficiency virus: differences in study outcomes. [Clin Infect Dis. 2001]
Review A review of efficacy studies of 6-month short-course therapy for tuberculosis among patients infected with human immunodeficiency virus: differences in study outcomes.
El-Sadr WM, Perlman DC, Denning E, Matts JP, Cohn DL. Clin Infect Dis. 2001 Feb 15; 32(4):623-32. Epub 2001 Feb 9.

See reviews... See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.

Recent activity

Clear Turn Off Turn On

FDA approves rifapentine for the treatment of pulmonary tuberculosis.... Food an...
FDA approves rifapentine for the treatment of pulmonary tuberculosis.... Food and Drug Administration.
J Int Assoc Physicians AIDS Care. 1998 Aug ;4(8):19-25.

PubMed
Local immunodiagnosis of pulmonary tuberculosis by enzyme-linked immunospot.
Local immunodiagnosis of pulmonary tuberculosis by enzyme-linked immunospot.
Eur Respir J. 2008 Feb ;31(2):261-5. Epub 2007 Nov 7 .

PubMed
Interferon-gamma release assays versus tuberculin skin testing for detection of ...
Interferon-gamma release assays versus tuberculin skin testing for detection of latent tuberculosis in chronic haemodialysis patients.
Nephrol Dial Transplant. 2009 Jun ;24(6):1952-6. Epub 2009 Jan 22 .

PubMed
QuantiFERON®-CMV assay for the assessment of cytomegalovirus cell-mediated immun...
QuantiFERON®-CMV assay for the assessment of cytomegalovirus cell-mediated immunity.
Expert Rev Mol Diagn. 2011 Jan ;11(1):17-25.

PubMed
Evaluation of an interferon-gamma release assay, T-SPOT.TB, in a population with...
Evaluation of an interferon-gamma release assay, T-SPOT.TB, in a population with a low prevalence of tuberculosis.
Int J Tuberc Lung Dis. 2009 Nov ;13(11):1416-21.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to: